PF-05212377

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NamePF-05212377
Drug Alias NameSAM-760PF-5212377WYE-103760PF-05212377
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 6 (5-HT6) receptor antagonists
TargetsSerotonin 6 (5-HT6) receptor
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A